Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative delirium in elderly abdominal surgery
ChiCTR2600120499Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Onset time, frequency, and duration of postoperative delirium. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600120499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120499.